| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/29/2004 | WO2004035589A1 Heterocyclocarboxamide derivatives |
| 04/29/2004 | WO2004035577A2 Pre-organized tricyclic integrase inhibitor compounds |
| 04/29/2004 | WO2004035576A2 Pre-organized tricyclic integrase inhibitor compounds |
| 04/29/2004 | WO2004035570A1 Large conductance calcium-activated k channel opener |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/29/2004 | WO2004012732A3 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082778 Amination process |
| 04/29/2004 | US20040082759 Process for preparing distamycin derivatives |
| 04/29/2004 | US20040082724 Novel heterobifunctional monomers and uses therefor |
| 04/29/2004 | US20040082663 Imidazoline receptor binding compounds |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 04/29/2004 | US20040082611 Novel sulfonyl derivatives |
| 04/29/2004 | US20040082586 Insecticides, nematocides |
| 04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082477 Pyrrolecarboxamides for the use as fungicdes |
| 04/29/2004 | US20040081620 Measurement anticoagulant |
| 04/29/2004 | CA2501979A1 Large conductance calcium-activated k channel opener |
| 04/29/2004 | CA2501881A1 Pre-organized tricyclic integrase inhibitor compounds |
| 04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/28/2004 | EP1414088A1 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 04/28/2004 | EP1413886A1 Sensor surface |
| 04/28/2004 | EP1413574A1 Pyrrolidine derivatives and method of synthesizing these |
| 04/28/2004 | EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 04/28/2004 | EP1412329A1 Methods of making pyrrolidones |
| 04/28/2004 | EP1412328A1 Dolastatin 10 derivatives |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1412078A1 Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof |
| 04/28/2004 | EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors |
| 04/28/2004 | EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 04/28/2004 | EP1051394B1 Potassium channel inhibitors |
| 04/28/2004 | EP0990646B1 Process for preparing 3-(7-amidino-2-naphthyl)-2-phenylpropionic acid derivatives |
| 04/28/2004 | EP0719253B1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 04/28/2004 | EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them |
| 04/28/2004 | CN1147504C New thrombin inhibitors, their preparation and use |
| 04/28/2004 | CN1147483C Adamantane derivatives |
| 04/28/2004 | CN1147459C Galcium receptor-active compound |
| 04/27/2004 | US6727368 Oligomers and polymers of cyclic imino carboxylic acids |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727270 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 04/27/2004 | US6727267 NS5B HVC polymerase inhibitors |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6726811 Method of purifying N-(2-hydroxyethy)-2-pyrrolidone |
| 04/27/2004 | CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds |
| 04/22/2004 | WO2004033425A1 Pyrrolidine derivatives for use in treating heaptitis c virus infection |
| 04/22/2004 | WO2004033424A1 Watersoluble prodrugs of propofol |
| 04/22/2004 | WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 04/22/2004 | WO2004033397A2 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | WO2004032827A2 Hepatitis c virus inhibitors |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2003101958A3 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 04/22/2004 | WO2000061134A9 Antimicrobial agents |
| 04/22/2004 | US20040077890 Complexed compounds and use thereof for the polymerisation of olefins |
| 04/22/2004 | US20040077881 $G(d)1-pyrrolines used in pest control |
| 04/22/2004 | US20040077880 Sulfonylpyrroles |
| 04/22/2004 | US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings |
| 04/22/2004 | US20040077874 Novel monomers and energy polymerizable compositions; use as waveguides in telecommunications industry |
| 04/22/2004 | US20040077865 Making 1-amino-6-nitroisoquinoline by reacting beta-(dimethylamino)-2-cyano-5-nitro-styrene with lithium hexamethyldisilazane or reacting said styrene compound with 2,4-dimethoxybenzylamine and then with anisole |
| 04/22/2004 | US20040077856 Peptide deformylase inhibitors |
| 04/22/2004 | US20040077852 Para-phenylenediamine derivatives containing a pyrrolidyl group, and use of these derivatives for coloring keratin fibers |
| 04/22/2004 | US20040077798 Thermosetting resin compositions containing maleimide and/or vinyl compounds |
| 04/22/2004 | US20040077709 Neuronal death inhibitors |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
| 04/22/2004 | US20040077550 One pot process; forming acryloyl-guanidino derivatives |
| 04/22/2004 | US20040077021 Haptens, intermediates, and immunogens that are useful in the production of antibodies specific for the methylenedioxy class of amphetamine derivatives |
| 04/22/2004 | CA2501831A1 Activity-based probes, and methods of their preparation and use |
| 04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 04/21/2004 | EP1409455A1 Prostaglandin analogues-as ep4 receptor agonists |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1409440A1 A method to inhibit ethylene responses in plants |
| 04/21/2004 | EP1409122A2 Catalytic compositions and methods for asymmetric aldol reactions |
| 04/21/2004 | EP1408961A1 2 pyrrolidone derivatives as prostanoid agonists |
| 04/21/2004 | EP1320525B1 Antibacterial mutilins |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491237A Complexed compounds and use thereof for polymerization of olefins |
| 04/21/2004 | CN1491213A Novel benzoylguanidine salt |
| 04/21/2004 | CN1491212A Pyrrolecarboxamides for use as fungicides |
| 04/21/2004 | CN1491211A G(D)1-pyrrolines used in pest control |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1490311A Bafuluomaidi as alpha No. subacceptor for blocking sympathetic nerve |
| 04/21/2004 | CN1146560C Substituted benzoylpyrazoles as herbicides |
| 04/21/2004 | CN1146538C Process for preparation of zofenopril calcium salt |
| 04/20/2004 | US6723856 Dissolving proline in dry alcohol, cooling to -5 c. to -15 c., thionylchloride, alkali carbonate, distilling, dissolving the 2-carbomethoxy-1-pyrrolidine in ether, methylmagnesium iodide grignard |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
| 04/20/2004 | CA2215585C Practical synthesis of urea derivatives |
| 04/15/2004 | WO2004031248A1 Novel nitrosation polymer in organic synthesis |
| 04/15/2004 | WO2004031171A1 Isoquinoline compounds and medicinal use thereof |
| 04/15/2004 | WO2004031148A1 Piperazine and piperidine derivatives for treatment of neurological diseases |
| 04/15/2004 | WO2004031147A1 Production of n-vinyl pyrrolidone |